Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

Université de Montréal

$27,000.00

Associations between neuroinflammation, cerebral hamartomas, drug-resistant epilepsy, and neuropsychiatric conditions in Tuberous Sclerosis Complex.

EF 2024-25

Résumé
Tuberous Sclerosis Complex (TSC) is a genetic disease that manifests during childhood, leading to the growth of tumours in many organs. People with TSC (pwTSC) carry faulty genes that normally control cell growth and inflammation. A great proportion of pwTSC have devastating symptoms that prevent their daily functioning. The severity of these manifestations, however, can vary dramatically between individuals.The majority of pwTSC have brain tumours (tubers) and suffer from epilepsy. Some people also have drug-resistant epilepsy (DRE) or severe intellectual disability, while others do not. Although a few drug therapies have addressed these symptoms, the degree of response varies widely among individuals. It is crucial to understand why TSC manifests more severely in some individuals than in others, and what influences resistance to treatment. In this way, physicians can provide personalized treatment strategies for pwTSC and alleviate the burden of the disease. I am interested in the role of dysregulated inflammation in disease severity and treatment response in pwTSC. Prior studies have shown that many inflammatory molecules are elevated in the blood of pwTSC, or those with DRE. The extent to which inflammation and tubers contribute to symptoms in TSC remains unclear. To elucidate this relationship, I will analyze blood samples from the largest TSC cohort in Canada. Using laboratory techniques, I will measure the levels of inflammatory markers in the blood. Working with the radiology team, I will use brain imaging to measure their tuber characteristics. These measurements will be analyzed to uncover associations between inflammation, tuber characteristics, and important clinical outcomes including epilepsy severity, intellectual disability and autistic traits.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
530122
Name
Boulanger Jakob
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Associations between neuroinflammation, cerebral hamartomas, drug-resistant epilepsy, and neuropsychiatric conditions in Tuberous Sclerosis Complex.
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Autism Spectrum Disorder; Brain Hamartoma; Drug-Resistant Epilepsy; Epilepsy; Genetic Disorder; Inflammation; Intellectual Disability; Mtor; Neuroimmunology; Tuberous Sclerosis Complex
Abstract
Tuberous Sclerosis Complex (TSC) is a genetic disease that manifests during childhood, leading to the growth of tumours in many organs. People with TSC (pwTSC) carry faulty genes that normally control cell growth and inflammation. A great proportion of pwTSC have devastating symptoms that prevent their daily functioning. The severity of these manifestations, however, can vary dramatically between individuals.The majority of pwTSC have brain tumours (tubers) and suffer from epilepsy. Some people also have drug-resistant epilepsy (DRE) or severe intellectual disability, while others do not. Although a few drug therapies have addressed these symptoms, the degree of response varies widely among individuals. It is crucial to understand why TSC manifests more severely in some individuals than in others, and what influences resistance to treatment. In this way, physicians can provide personalized treatment strategies for pwTSC and alleviate the burden of the disease. I am interested in the role of dysregulated inflammation in disease severity and treatment response in pwTSC. Prior studies have shown that many inflammatory molecules are elevated in the blood of pwTSC, or those with DRE. The extent to which inflammation and tubers contribute to symptoms in TSC remains unclear. To elucidate this relationship, I will analyze blood samples from the largest TSC cohort in Canada. Using laboratory techniques, I will measure the levels of inflammatory markers in the blood. Working with the radiology team, I will use brain imaging to measure their tuber characteristics. These measurements will be analyzed to uncover associations between inflammation, tuber characteristics, and important clinical outcomes including epilepsy severity, intellectual disability and autistic traits.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Boulanger, Jakob
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~